Haematopoietic stem cell transplantation in systemic sclerosis

Three randomised controlled trials of haematopoietic stem cell transplantation (HSCT) in systemic sclerosis (SSc) demonstrated long-term survival benefits, induction of clinically meaningful, sustained improvement of forced vital capacity with improvements in skin thickening, vasculopathy and health...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:RMD Open
Asıl Yazarlar: Walker, Ulrich A, Saketkoo, Lesley Ann, Distler, Oliver
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2018
Konular:
Systemic Sclerosis
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6045702/
https://ncbi.nlm.nih.gov/pubmed/30018796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2017-000533
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller